When was Cardionomic founded?

Cardionomic was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Where is Cardionomic located?

Cardionomic is headquartered in Forest Lake, United States. It is registered at New Brighton, Minnesota.

How many employees does Cardionomic have?

As of Dec 22, 2025, the latest employee count at Cardionomic is 4.

Is Cardionomic a funded company?

Cardionomic is a funded company, having raised a total of $46.7M across 4 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Oct 16, 2015.

When was the latest funding round of Cardionomic?

Cardionomic's latest funding was a $***** Conventional Debt round on Oct 04, 2021, with participation from 0 investor.

Where does Cardionomic rank among its competitors?

Cardionomic ranks 21st amongst 97 active competitors, of which 57 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was FineHeart, which secured $40.8M in Jan, 2026.

Who are the top competitors of Cardionomic?

Cardionomic's top competitors include CVRx, Impulse Dynamics and Adona Medical. Among them, FineHeart secured the most recent funding round in January, 2026.

Cardionomic - 2026 Company Profile, Funding & Competitors

Cardionomic is a deadpooled company based in Forest Lake (United States), founded in 2012. It operates as a Neuromodulation therapy for heart failure. Cardionomic has raised $46.7M in funding. The company has 97 active competitors, including 57 funded and 15 that have exited. Its top competitors include companies like CVRx, Impulse Dynamics and Adona Medical.

Company Details

Cardionomic is developing a neuromodulation device to treat acute decompensated heart failure, in which fluid builds up in the lungs of patients. Hospitals admit 1 million people annually with the condition, which is currently treated with medications. The company has been issued 2 primary patents.

Website: www.cardionomicinc.com/
Registered Address: New Brighton, Minnesota

Key Metrics

Founded Year

2012

Location

Forest Lake, United States

Stage

Deadpooled

Total Funding

$46.7M in 4 rounds

Latest Funding Round

Conventional Debt, Oct 04, 2021, $*****

Investors

New Enterprise Associates & 3 more

Ranked

21^st among 97 active competitors

Employee Count

4 as on Dec 22, 2025

Similar Companies

CVRx & 123 more

View Cardionomic's full profile

Cardionomic is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CARDIONOMIC RETIREMENT, INC. CIN: 263662474 , United States, Active	Dec 31, 1999	-	16 (As on Dec 31, 2023)	-

Cardionomic has raised a total funding of $46.7M over 4 rounds. Its first funding round was on Oct 16, 2015. Cardionomic has 4 institutional investors.

Here is the list of recent funding rounds of Cardionomic:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 04, 2021	2146424	Conventional Debt	4294418	4450963	4623650	6218344
Feb 21, 2020	8110260	Series C	1977971	4667760	8264953	4072654
May 01, 2018	7917356	Series B	2886025	2424817	1164792	7755888

Access funding benchmarks and valuations. Sign up today!

View details of Cardionomic's funding rounds and investors

Cardionomic's employee count trend

Cardionomic has 4 employees as of Dec 25. Here is Cardionomic's employee count trend over the years:

Uncover Cardionomic's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cardionomic include CVRx, Impulse Dynamics and Adona Medical. Here is the list of Top 10 competitors of Cardionomic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CVRx 2001, Minneapolis (United States), Public	Developer of implantable technology for hypertension and heart failure	$394M	Johnson & Johnson Innovation – JJDC, New Enterprise Associates ... & 20 others	67/100
2nd	Impulse Dynamics 1998, Marlton (United States), Series F	Provider of implantable device for treatment of chronic heart failure	$685M	Redmile Group, Perceptive Advisors & 16 others	64/100
3rd	Adona Medical 2017, Campbell (United States), Series C	Developer of medical devices for the management of heart failure	$71M	Cormorant Asset Management, The Capital Partnership ... & 7 others	64/100
4th	Element Science 2013, San Francisco (United States), Series C	Wearable therapeutic device for treating sudden cardiac arrest	$193M	Deerfield, Qiming & 4 others	61/100
5th	CorWave 2011, Paris (France), Series C	Developer of implantable blood pumps for the treatment of heart failure	$127M	Ysios Capital, Seventure Partners & 11 others	61/100
6th	SynCardia 2001, Tucson (United States), Public	Artificial heart	$72M	SWK Holdings, Athyrium Capital Management ... & 5 others	60/100
7th	Corvia Medical 2009, Tewksbury (United States), Acquired	Developer of transcatheterally shunt for treating diastolic heart failure disease	$160M	Edwards Lifesciences, Accelmed & 4 others	60/100
8th	Reprieve Cardiovascular 2018, Milford (United States), Series B	Developer of decongestion management solution for acute decompensated heart failure patients	$150M	Deerfield, Arboretum Ventures & 8 others	58/100
9th	FineHeart 2010, Pessac (France), Series C	Developer of an implantable cardiovascular device for treating heart failures	$51.9M	Broadview Ventures, Verve Ventures & 16 others	57/100
10th	Restore Medical 2016, Tel Aviv (Israel), Series B	Catheter-delivered implant for treatment of congestive heart failure	$32M	European Commission, Pitango & 3 others	57/100
21st	Cardionomic 2012, Forest Lake (United States), Deadpooled	Neuromodulation therapy for heart failure	$46.7M	New Enterprise Associates, Ascension Ventures ... & 2 others	45/100